Company / SG&A per Share
Arcturus Therapeutics Holdings Inc. SG&A per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.71
FY2025
5-year range
$1.57 / $1.99
FY2021-FY2025
Trend
-13.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share has fluctuated over the past 7 years, ranging from $1.36 in FY2020 to $1.99 in FY2023.
Based on SEC 10-K filings.
1.71 in FY2025 with a 5-year CAGR of +4.7%.
Improved from $1.99 to $1.71 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +2.8%
- 5-Year CAGR
- +4.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, sg&a per share decreased 13.3% year-over-year.
- Peak sg&a per share was recorded in FY2023.
- Lowest sg&a per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.06 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.71 | -13.3% |
| FY2024 | $1.97 | -1.1% |
| FY2023 | $1.99 | +26.7% |
| FY2022 | $1.57 | -0.7% |
| FY2021 | $1.58 | +16.4% |
| FY2020 | $1.36 | -29.2% |
| FY2019 | $1.92 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026